Clareo Health | Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy
Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Samsung Medical Center
Age
Any age
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
patients diagnosed with prostate cancer in biopsy
among patients with biochemical recurrence after treatment(radical prostatectomy, radiation therapy, focal therapy, etc.) for localized prostate cancer or metastatic prostate cancer at the time of diagnosis, who received intermittent androgen deprivation therapy(IAD)
patients who off-treatment for the first time by receiving androgen deprivation therapy(ADT) for more than 6 months and PSA nadir remained stable for more than 3 months
You may not be if
previous history of IAD
patient with other serious or ongoing medical or psychiatric disease other than prostate cancer
hypersensitivity or suspicious of curcumin
history of taking health supplements containing curcumin for prostate cancer treatment before 6 months of clinical trial participation
